Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
ArcelorMittal heads into November earnings with its sharpest monthly selloff in recent memory and analysts still pricing the stock well above where the market is trading it.
The price action tells the most urgent story this week. Shares closed at €55.58 on Wednesday, down 4.6% on the day and 6.4% on the week, extending a 17% one-month decline that has erased most of the gains that pushed the stock's momentum score to a multiyear high just two weeks ago. That reversal is abrupt: as recently as late September, an ORTEX stock-score note flagged a momentum reading of 86.5, driven by relative strength across three time horizons and a 50-day moving average sitting nearly 18% above the 200-day. That gap is now closing fast. The next earnings print is scheduled for 5 November.
The selloff has not drawn in a fresh wave of short sellers, and the lending market is under no visible stress. Short-score readings have barely moved, drifting from 26.7 to 26.3 over the past two weeks, a low absolute level. Borrow availability is extremely loose, running above 6,350% of outstanding short interest, meaning there are roughly 63 shares available to lend for every one already borrowed. Cost to borrow is negligible at under 0.60%, and has actually fallen about 8% on the week. The one anomaly in the borrow data is a brief spike to 6.3% on 30 September, which resolved quickly, suggesting a momentary settlement quirk rather than genuine squeeze pressure. This is a stock being sold, not shorted aggressively.
The Street's price target paints a very different picture from where shares trade today. The mean analyst target is €77.06, implying roughly 39% upside from current levels. No recent analyst moves are in the data, so that consensus reflects positioning from before the October slide. Valuation multiples have compressed alongside the price: the price-to-book ratio has fallen to 0.79, down sharply over the past 30 days, while EV/EBITDA has compressed to 5.7x. The earnings yield factor score ranks in the 90th percentile on short score rank and the 97th on dividend yield, flagging that ArcelorMittal screens as deep value for quant strategies that weight those factors. The EV/EBIT score, however, sits in the 33rd percentile, reflecting higher capital intensity relative to peers. The Benzinga bear case on the stock, captured in a note from late September, centres on weakening construction and automotive end-demand heading into Q4 and the company's sensitivity to cyclical downturns, a thesis the market appears to be repricing this week.
Peer moves this week confirm this is a sector-wide reset, not an ArcelorMittal-specific story. SZG fell 10.4% over the week and APAM dropped 12.5%, both with higher correlations to MT than most names in the group. TKA gave back 8.4%. Only KGH managed a positive week, up 1.5%. The breadth of the decline across European steel and metals names points to macro demand as the driver rather than company-specific news.
One structural feature worth noting is the ownership register. Grandel Pte Limited, the Mittal family holding vehicle, controls 45% of the company and filed a Schedule 13D amendment in March disclosing a stake of 44.7%. Lakshmi N. Mittal is listed as an activist filer on that register, though the filing reflects a controlling rather than an externally activist position. As required disclosure: 13D/G stakes are event-driven around the 5% threshold, and the figure is as last reported in March. Among institutional holders, BlackRock added roughly 841,000 shares in the quarter to September, and Fidelity (FMR LLC) added around 696,000, both modest increases that suggest passive or benchmark-driven buying rather than conviction accumulation.
The 5 November earnings date is the next hard catalyst. ArcelorMittal's two most recent prints produced meaningful positive reactions: a 5.1% gain on the day and 10.5% over the five days following the July 2026 result, and a smaller 2.8% one-day drop followed by an 8.9% five-day recovery after the April print. Whether the current 17% pre-earnings decline has already discounted a weak Q3 read, or whether consensus targets need a further reset, is the question the market is now pricing ahead of that release.
See the live data behind this article on ORTEX.
Open MT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
